Citigroup’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.5M | Buy |
724,899
+650,592
| +876% | +$8.53M | ﹤0.01% | 1027 |
|
|
2025
Q1 | $1.63M | Sell |
74,307
-4,190
| -5% | -$92.2K | ﹤0.01% | 2232 |
|
|
2024
Q4 | $2.1M | Buy |
78,497
+2,656
| +4% | +$70.9K | ﹤0.01% | 2100 |
|
|
2024
Q3 | $2.02M | Buy |
75,841
+52,788
| +229% | +$1.41M | ﹤0.01% | 2032 |
|
|
2024
Q2 | $415K | Sell |
23,053
-13,891
| -38% | -$250K | ﹤0.01% | 2805 |
|
|
2024
Q1 | $674K | Buy |
36,944
+29,683
| +409% | +$541K | ﹤0.01% | 2651 |
|
|
2023
Q4 | $79.4K | Buy |
7,261
+6,083
| +516% | +$66.5K | ﹤0.01% | 3558 |
|
|
2023
Q3 | $6.75K | Sell |
1,178
-13,108
| -92% | -$75.1K | ﹤0.01% | 3926 |
|
|
2023
Q2 | $111K | Buy |
14,286
+13,567
| +1,887% | +$105K | ﹤0.01% | 3528 |
|
|
2023
Q1 | $4.8K | Sell |
719
-204
| -22% | -$1.36K | ﹤0.01% | 4260 |
|
|
2022
Q4 | $8.25K | Sell |
923
-141
| -13% | -$1.26K | ﹤0.01% | 4192 |
|
|
2022
Q3 | $10K | Sell |
1,064
-1,949
| -65% | -$18.3K | ﹤0.01% | 4244 |
|
|
2022
Q2 | $24K | Buy |
3,013
+562
| +23% | +$4.48K | ﹤0.01% | 4194 |
|
|
2022
Q1 | $24K | Sell |
2,451
-8,885
| -78% | -$87K | ﹤0.01% | 4320 |
|
|
2021
Q4 | $173K | Buy |
11,336
+9,839
| +657% | +$150K | ﹤0.01% | 3677 |
|
|
2021
Q3 | $25K | Buy |
1,497
+910
| +155% | +$15.2K | ﹤0.01% | 4372 |
|
|
2021
Q2 | $13K | Buy |
+587
| New | +$13K | ﹤0.01% | 4855 |
|